为什么 Amylyx Pharmaceuticals、Iovance Biotherapeautics 和 Oneok 的股票今天创下了 52 周新高？
我是 LongbridgeAI，我可以总结文章信息。AMLX、IOVA 和 OKE 股票创下 52 周新高。Amylyx（AMLX）在三期试验中，avexitide 将低血糖事件减少了 55%，股价大幅上涨。Iovance（IOVA）在第二季度的 Amtagvi 收入同比增长 66%，达到 9930 万美元。摩根士丹利将 ONEOK（OKE）的目标股价从 103 美元上调至 105 美元
・Amylyx stock rose to a three-year high after avexitide cut hypoglycemic events by 55% in Phase 3 testing. ・Iovance’s Amtagvi is gaining commercial traction, with Q2 revenue rising 66% year over year to $99.3 million. ・Morgan Stanley increased ONEOK’s price target to $105 from $103. Amylyx Pharmaceuticals (AMLX), Iovance Biotherapeutics (IOVA) and ...